Does ATEZOLIZUMAB Cause Device occlusion? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Device occlusion have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.1% of all adverse event reports for ATEZOLIZUMAB.
20
Reports of Device occlusion with ATEZOLIZUMAB
0.1%
of all ATEZOLIZUMAB reports
8
Deaths
17
Hospitalizations
How Dangerous Is Device occlusion From ATEZOLIZUMAB?
Of the 20 reports, 8 (40.0%) resulted in death, 17 (85.0%) required hospitalization.
Is Device occlusion Listed in the Official Label?
Yes, Device occlusion is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Device occlusion?
PEGFILGRASTIM (3,239)
CARBIDOPA\LEVODOPA (1,464)
SOMATROPIN (823)
LEUPROLIDE (786)
EPOPROSTENOL (580)
TREPROSTINIL (458)
ALBUTEROL (431)
MEDROXYPROGESTERONE (284)
BACLOFEN (254)
LEVODOPA (224)
Which ATEZOLIZUMAB Alternatives Have Lower Device occlusion Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN